Farallon Capital Management’s Apellis Pharmaceuticals APLS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $241K | Buy |
|
|||||
|
2024
Q3 | – | Sell |
|
|||||
|
2024
Q2 | $230K | Hold |
|
|||||
|
2024
Q1 | $353K | Hold |
|
|||||
|
2023
Q4 | $359K | Sell |
|
|||||
|
2023
Q3 | $7.38M | Buy |
|
|||||
|
2023
Q2 | $3.65M | Sell |
|
|||||
|
2023
Q1 | $20.9M | Sell |
|
|||||
|
2022
Q4 | $23.3M | Sell |
|
|||||
|
2022
Q3 | $32.6M | Buy |
|
|||||
|
2021
Q3 | – | Sell |
|
|||||
|
2021
Q2 | $98M | Sell |
|
|||||
|
2021
Q1 | $93.3M | Sell |
|
|||||
|
2020
Q4 | $130M | Hold |
|
|||||
|
2020
Q3 | $68.6M | Buy |
|
|||||
|
2020
Q2 | $73.5M | Buy |
|
|||||
|
2020
Q1 | $53.6M | Buy |
|
|||||
|
2019
Q4 | $15.3M | Buy |
|